skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Long Peptide Vaccine 7 (Code C116067)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Long Peptide Vaccine 7

Definition: A peptide vaccine consisting of a combination of seven synthetic long peptides (SLPs), which are each about 30 amino acids in size, and derived from cancer-testis antigens (CTA) and melanocytic differentiation proteins (MDP), with potential immunostimulating and antitumor activities. Upon administration, long peptide vaccine 7 may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against tumor cells expressing these peptides. CTA and MDP are overexpressed in a variety of cancer cell types.

Label: Long Peptide Vaccine 7

NCI Thesaurus Code: C116067 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL473486  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Long Peptide Vaccine 7

External Source Codes: 
PDQ Closed Trial Search ID 760895
PDQ Open Trial Search ID 760895 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C116067
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom